Pharmaceutical

Catholic Charities USA to launch nationwide storytelling exhibit thanks to grant from Lilly Endowment

ALEXANDRIA, Va., April 23, 2025 /PRNewswire/ -- Catholic Charities USA (CCUSA) announced this month to the Catholic Charities network that…

8 months ago

Axtria Unveils Transformational Agentic AI Platform to Help Life Sciences Companies Deploy, Scale, and Monetize Innovation

Axtria InsightsMAx.ai Delivers an Enterprise-Grade Flexible Framework with 30+ Ready-to-Deploy Agents, Apps, and APIs BERKELEY HEIGHTS, N.J., April 23, 2025…

8 months ago

Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025

— Oral presentation Tuesday, June 3, 2025 in Chicago — LOS ANGELES, April 23, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma,…

8 months ago

Bicara Therapeutics to Present Updated Data from Ongoing Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative…

8 months ago

Immatics Announces Upcoming Oral and Poster Presentation on IMA203 TCR T-cell Therapy at 2025 ASCO Annual Meeting

Houston, Texas and Tuebingen, Germany, April 23, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company…

8 months ago

ITULAZAX® tree pollen tablet approved for treatment of children in Europe

ALK (ALKB.DC / OMX: ALK B) today announced that its European regulatory filing for ITULAZAX® (tree pollen sublingual allergy immunotherapy…

8 months ago

Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery

Press release – No. 5 / 2025 Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide…

8 months ago

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Multi-Contact Probe Provides Alternative to Pharmaceutical and Invasive Surgical Treatments Submission Completed Earlier Than Anticipated EDEN PRAIRIE, Minn., April 23,…

8 months ago

Conavi Medical Corp. Announces Closing of $20M Public Offering

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 23, 2025 (GLOBE…

8 months ago